Is BOLD or BTAI more undervalued in 2026?

CirclFi compares Boundless Bio, Inc. (BOLD) and BioXcel Therapeutics, Inc. (BTAI) using 13 institutional-grade valuation models. BOLD has a Quality of Company score of 4.0/10 while BTAI scores 4.4/10.

Which is a better buy — BOLD or BTAI?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do BOLD and BTAI valuations compare?

BOLD at $1.45 and BTAI at $1.17 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

BOLD vs BTAI Valuation Comparison 2026 — Intrinsic Value Analysis

BOLD

Pharmaceutical Preparations

Boundless Bio, Inc.

Quality

4.0

out of 10

Value Trap

SAFE

Price

$1.45

Last close

Models

7/13

Active

BTAI

Pharmaceutical Preparations

BioXcel Therapeutics, Inc.

Quality

4.4

out of 10

Value Trap

SAFE

Price

$1.17

Last close

Models

4/13

Active

Model-by-Model Comparison

Model	Type	BOLD Fair Value	BOLD Upside	BTAI Fair Value	BTAI Upside
Bayesian DCF	Intrinsic	$0.75	-48.6%	—	—
EROIC Spread	Intrinsic	—	—	$1.49	+24.3%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$2.77	+91.3%	$0.05	-95.5%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$3.51	+142.0%	$3.95	+237.3%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for BOLD vs BTAI — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

BOLD vs BTAI — Which Stock Is More Undervalued?

BTAI scores higher with a 4.4/10 quality rating vs BOLD's 4.0/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Boundless Bio, Inc. (BOLD) and BioXcel Therapeutics, Inc. (BTAI) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

BOLD currently trades at $1.45 with a QOC of 4.0/10, while BTAI trades at $1.17 with a QOC of 4.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).